Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real-world data.
Ying PengPeihong XuJuan ShiYifei ZhangShujie WangQidong ZhengYufan WangTingyu KeLi LiDong ZhaoYuancheng DaiQijuan DongBangqun JiFengmei XuWeiqiong GuWeiqing WangPublished in: Journal of diabetes (2022)
In this real-world study, once-daily basal insulin was more frequently prescribed and had similar glycemic control effects but less weight gain compared with twice-daily premixed insulin when used as initiation therapy for those in whom glycemic control with non-insulin medications failed.
Keyphrases
- glycemic control
- type diabetes
- blood glucose
- weight gain
- weight loss
- insulin resistance
- body mass index
- end stage renal disease
- newly diagnosed
- birth weight
- ejection fraction
- cardiovascular disease
- chronic kidney disease
- prognostic factors
- electronic health record
- machine learning
- clinical trial
- cross sectional
- artificial intelligence
- data analysis